Share on StockTwits

Ardelyx (NASDAQ:ARDX) major shareholder Ventures Vii Lp Cmea acquired 316,826 shares of Ardelyx stock in a transaction dated Tuesday, June 24th. The shares were purchased at an average price of $14.00 per share, with a total value of $4,435,564.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Ardelyx (NASDAQ:ARDX) traded up 0.49% during mid-day trading on Thursday, hitting $15.526. The stock had a trading volume of 33,619 shares. Ardelyx has a 1-year low of $14.05 and a 1-year high of $16.00. The stock’s 50-day moving average is $14.9 and its 200-day moving average is $14.9. The company’s market cap is $19.7 million.

Ardelyx, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of non-systemic, small molecule therapeutics that work in the gastrointestinal (NASDAQ:ARDX), tract to treat cardio-renal, GI and metabolic diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.